Manreet Kaur, MD, on Whether Precision Medicine is Ready for Prime Time

Dr Kaur reviews her presentation from the virtual Advances in Inflammatory Bowel Disease regional meeting on the development of precision medicine in treatment of IBD.

Additional Resources:


AIBD newsroom

For more information about AIBD 2020 and to register for the AIBD Annual Meeting in December, visit

Manreet Kaur, MD, is director of the Inflammatory Bowel Disease Center at Baylor College of Medicine in Houston, Texas.


Submit Feedback